AIM
LH icon

Acrospire Investment Management’s Labcorp LH Stock Holding History

Acrospire Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-821
Closed -$109K – 789
2017
Q2 		$109K Buy
821
+117
+17% +$14.3K 0.1% 204
2017
Q1 		$87K Buy
704
+233
+49% +$27.6K 0.07% 423
2016
Q4 		$52K Sell
471
-582
-55% -$64.7K 0.02% 1380
2016
Q3 		$124K Sell
1,053
-233
-18% -$27.5K 0.08% 383
2016
Q2 		$144K Buy
1,286
+465
+57% +$50K 0.11% 215
2016
Q1 		$83K Buy
+821
New +$78.7K 0.06% 457

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Acrospire Investment Management's LH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Labcorp (LH) in Q3 2017, closing a stake of 821 shares — an estimated $109K sold.

Acrospire Investment Management first reported a position in LH in Q1 2016 and held it in 6 quarters. The position peaked at $144K in Q2 2016. 701 funds tracked by Wall St. Rank hold LH as of Q3 2017.

  • Acrospire Investment Management reported no remaining Labcorp position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 821 Labcorp shares in Q3 2017, an estimated $109K.
  • Acrospire Investment Management first reported a position in Labcorp in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Labcorp position peaked at $144K in Q2 2016.
  • 701 funds tracked by Wall St. Rank held Labcorp as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.